Polymer Protects Mouse Heart

Injection of microscopic particles of a plastic-like material protects mice from cardiac tissue damage following heart attack.

By | January 20, 2014

WIKIMEDIA, RAMAThe worst part of a heart attack isn’t always due to the temporary stoppage of blood flow to the organ; rather, it’s the body’s natural immune response to the damaged muscle. But new research shows that microscopic biodegradable particles capable of blocking such inflammation can protect mice from the continued tissue damage, and help strengthen cardiac function in the first month following a heart attack. The new study was published last week (January 15) in Science Translational Medicine.

The heart-helping particles are 500 nanometers and must negatively charged, though there are several different materials that can work, including polystyrene, microdiamonds, or biodegradable poly(lactic-co-glycolic) acid. In the bloodstream, the particles interact with inflammatory monocytes, causing them to be trafficked to the spleen—where they undergo apoptosis—rather than to the heart.

Daniel Getts, chief scientific officer of Cour Pharmaceutical Development and lead author on the study, and his colleagues suggest that such particles, termed immune-modifying microparticles (IMPs), may have a similar effect in humans. The team hopes to begin testing that possibility by early next year.

Of course, “there is still some homework to do,” Matthias Nahrendorf, a systems biology professor at Harvard University, told MIT Technology Review, including making sure that such an immune-modulating therapy does not increase patients’ risk of infection.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Paul Stein

Paul Stein

Posts: 174

January 21, 2014

Just because something like this appears in a "translation" journal doesn't mean it can be translated.  Way too much gets tried and then "stuck" in the mouse and advances no further, with millions of dollars in "hot topic" research dollars spent with nothing to show for it but some publications.  Before I can get excited about any new "therapy" for treating myocardial infarctions, I will want to see it work in a pig.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech